69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] CTSUALLIANCEURO031201-M 11/21/2014 [Summary] URO A031201: Phase III Trial of Enzalutamide (NSC # 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer [Trial Type] 
Treatment Prostate
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type